share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4:持股變動聲明-董事 Borgeson Blake
美股SEC公告 ·  08/22 18:50
Moomoo AI 已提取核心訊息
On August 20, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was carried out on the open market at a price of $7.1226 per share, resulting in a total sale value of approximately $81,532.40. Following this transaction, Borgeson directly holds a total of 7,132,769 shares in Recursion Pharmaceuticals.
On August 20, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was carried out on the open market at a price of $7.1226 per share, resulting in a total sale value of approximately $81,532.40. Following this transaction, Borgeson directly holds a total of 7,132,769 shares in Recursion Pharmaceuticals.
2024年8月20日,與Recursion Pharmaceuticals, Inc. [RXRX]相關的Blake Borgeson完成了對公司的A類普通股的11,447股的銷售。該交易在開放市場上以每股7.1226美元的價格進行,總銷售價值約爲81,532.40美元。在此交易之後,Borgeson在Recursion Pharmaceuticals直接持有總計7,132,769股。
2024年8月20日,與Recursion Pharmaceuticals, Inc. [RXRX]相關的Blake Borgeson完成了對公司的A類普通股的11,447股的銷售。該交易在開放市場上以每股7.1226美元的價格進行,總銷售價值約爲81,532.40美元。在此交易之後,Borgeson在Recursion Pharmaceuticals直接持有總計7,132,769股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息